by Alex Bajjon | May 1, 2020 | Briefings, US & International
Background This case is a preliminary ruling from the Courts of Justice of the European Union (CJEU) following a referral from the German Federal Patent Court regarding Supplementary Protection Certificates. In particular, the referral relates to Article 3(a) of EU...
by Alex Bajjon | Apr 1, 2020 | Briefings, US & International
Genentech owns US Patents 7,846,441 and 7,892,549 which both relate to treating cancers characterised by overexpression of the ErbB2 receptor (which includes breast cancers). The claims of these two patents relate to treating a human patient with a combination of an...
by Carolyn Haywood | Mar 1, 2020 | Briefings, US & International
Earlier this month, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its judgement in Illumina, Inc. v. Ariosa Diagnostics, Inc. and if the judgement stands, it may offer diagnostic companies a new way of navigating 35 U.S.C. § 101 – by way of...
by David Eyre | Feb 1, 2020 | Briefings, US & International
The Invention The invention in this case relates to drive shafts in automobiles (U.S. Patent 7,774,911; “‘911 patent”). Vibration in drive shafts is a known problem and methods have been devised to address this. Such methods include using drive shaft...
by David Eyre | Oct 1, 2019 | Briefings, UK, UPC, US & International
Currently, the cost of validating a European patent in multiple European jurisdictions can be prohibitive and a prudent Patentee may have to select a subset of EPO countries to protect their invention in. In contrast, the unitary patent offers the advantages of wider...
by Sean Hughes | Oct 1, 2019 | Briefings, US & International
Background US patents have a term of 20 years from the filing date of the patent application. A long period of prosecution, however, can effectively diminish the patent term, since a patent is only enforceable after grant. In an effort to make things fairer, the USPTO...
Recent Comments